The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
The efficacy ofSilybum marianum (L.) Gaertn. (silymarin) in the treatment of type II diabetes: a randomized, double-blind, placebo-controlled, clinical trial
Abstract
Oxidative stresses are increasingly implicated in the pathogenesis of diabetic complications which may either cause direct pancreatic beta-cell damage or lead to metabolic abnormalities that can induce or aggravate diabetes. The valuable effect of antioxidant nutrients on the glycemic control of diabetic patients has been reported in experimental and clinical studies. The present study was designed to investigate the effects of the herbal medicine, Silybum marianum seed extract (silymarin), which is known to have antioxidant properties on the glycemic profile in diabetic patients. A 4-month randomized double-blind clinical trial was conducted in 51 type II diabetic patients in two well-matched groups. The first group (n = 25) received a silymarin (200 mg) tablet 3 times a day plus conventional therapy. The second group (n = 26) received the same therapy but a placebo tablet instead of silymarin. The patients were visited monthly and glycosylated hemoglobin (HbA(1)c), fasting blood glucose (FBS), insulin, total cholesterol, LDL and HDL, triglyceride, SGOT and SGPT levels were determined at the beginning and the end of the study. The results showed a significant decrease in HbA(1)c, FBS, total cholesterol, LDL, triglyceride SGOT and SGPT levels in silymarin treated patients compared with placebo as well as with values at the beginning of the study in each group. In conclusion, silymarin treatment in type II diabetic patients for 4 months has a beneficial effect on improving the glycemic profile.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728
McGarry, J. D. (2002) · Diabetes · doi:10.2337/diabetes.51.1.7 · Cited by 1,435
Milk Thistle (Silybum marianum) for the Therapy of Liver Disease
Flora, K. (1998) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(97)00082-8 · Cited by 746
Maddux, B. A., See, W., Lawrence, J. C., Goldfine, A. L., Goldfine, I. D., & Evans, J. L. (2001) · Diabetes · doi:10.2337/diabetes.50.2.404 · Cited by 405
Evans, J. L., & Goldfine, I. D. (2000) · Diabetes Technology & Therapeutics · doi:10.1089/15209150050194279 · Cited by 228
Velussi, M., Cernigoi, A. M., Ariella, D. M., Dapas, F., Caffau, C., & Zilli, M. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80255-3 · Cited by 216
Silymarin increases antioxidant enzymes in alloxan-induced diabetes in rat pancreas
Soto, C., Recoba, R., Barrón, H., Alvarez, C., & Favari, L. (2003) · Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology · doi:10.1016/s1532-0456(03)00214-x · Cited by 188
Milk thistle: Silybum marianum
Pepping, J. (1999) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/56.12.1195 · Cited by 153
Rudich, A., Tirosh, A., Potashnik, R., Khamaisi, M., & Bashan, N. (1999) · Diabetologia · doi:10.1007/s001250051253 · Cited by 147
Cited by
Alterio, V., Di Fiore, A., D’Ambrosio, K., Supuran, C. T., & De Simone, G. (2012) · Chemical Reviews · doi:10.1021/cr200176r · Cited by 1,238
Silybin and the liver: From basic research to clinical practice
Loguercio, C. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i18.2288 · Cited by 375
Bensellam, M., Laybutt, D. R., & Jonas, J.-C. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.08.003 · Cited by 284
Chang, C. L. T., Lin, Y., Bartolome, A. P., Chen, Y.-C., Chiu, S.-C., & Yang, W.-C. (2013) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2013/378657 · Cited by 274
Loguercio, C., Andreone, P., Brisc, C., Brisc, M. C., Bugianesi, E., Chiaramonte, M., Cursaro, C., Danila, M., de Sio, I., Floreani, A., et al. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.02.008 · Cited by 267
A randomized trial of silymarin for the treatment of nonalcoholic steatohepatitis
Wah Kheong, C., Nik Mustapha, N. R., & Mahadeva, S. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.04.016 · Cited by 264
Toxicological and pharmacological concerns on oxidative stress and related diseases
Saeidnia, S., & Abdollahi, M. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.09.031 · Cited by 258
Antidiabetic phytoconstituents and their mode of action on metabolic pathways
Bharti, S. K., Krishnan, S., Kumar, A., & Kumar, A. (2018) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018818755019 · Cited by 222
Arentz, S., Abbott, J. A., Smith, C. A., & Bensoussan, A. (2014) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-14-511 · Cited by 191
Phytotherapy in diabetes: Review on potential mechanistic perspectives
El-Abhar, H. S., & Schaalan, M. F. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i2.176 · Cited by 145
Gupta Jain, S., Puri, S., Misra, A., Gulati, S., & Mani, K. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0504-8 · Cited by 115
Dietary supplements for diabetes: an evaluation of commonly used products
Shane-McWhorter, L. (2009) · Diabetes Spectrum · doi:10.2337/diaspect.22.4.206 · Cited by 20
Metadata
- Authors
- Huseini, H. F., Larijani, B., Heshmat, R., Fakhrzadeh, H., Radjabipour, B., Toliat, T., & Raza, M.
- Venue
- Phytotherapy Research
- Publisher
- Wiley
- Published
- 2006
- Volume
- 20
- Issue
- 12
- Pages
- 1036-1039
- ISSN
- 0951-418X (ISSN-L)
- 1099-1573
- OpenAlex
- W2117701880
- Cited by
- 262
- References
- 18
- FWCI
- 4.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.